Latest period
$3.88B
YoY change
-0.2%
5Y CAGR
+6.3%
Peak year (2022)
$5.65B
Latest annual
$3.92B
Total Liabilities history chart for Illumina (ILMN) from 1999 to 2025
Latest: $3.92B
Total Liabilities growth chart for Illumina (ILMN) from 1999 to 2025
Latest: -0.2%
Total Liabilities history table for Illumina (ILMN) from 1999 to 2025
| 2025 | $3.92B | -0.2% | −$9.00M | ||
| 2024 | $3.93B | -10.0% | −$436.00M | ||
| 2023 | $4.37B | -22.8% | −$1.29B | ||
| 2022 | $5.65B | +26.3% | +$1.18B | ||
| 2021 | $4.48B | +54.9% | +$1.59B | ||
| 2020 | $2.89B | +7.0% | +$188.00M | ||
| 2019 | $2.70B | -11.5% | −$350.00M | ||
| 2018 | $3.05B | +33.4% | +$765.00M | ||
| 2017 | $2.29B | +16.4% | +$321.57M | ||
| 2016 | $1.97B | +8.8% | +$159.78M | ||
| 2015 | $1.81B | -3.7% | −$70.19M | ||
| 2014 | $1.88B | +26.3% | +$391.04M | ||
| 2013 | $1.49B | +19.1% | +$238.30M | ||
| 2012 | $1.25B | +11.3% | +$126.88M | ||
| 2011 | $1.12B | +74.7% | +$479.19M | ||
| 2010 | $641.44M | +13.4% | +$75.75M | ||
| 2009 | $565.69M | +7.0% | +$37.19M | ||
| 2008 | $528.50M | -8.3% | −$47.55M | ||
| 2007 | $576.05M | +982.0% | +$522.81M | ||
| 2006 | $53.24M | +89.4% | +$25.13M | ||
| 2005 | $28.11M | +24.1% | +$5.47M | ||
| 2004 | $22.64M | -56.3% | −$29.20M | ||
| 2003 | $51.85M | +3.4% | +$1.68M | ||
| 2002 | $50.16M | +220.0% | +$34.49M | ||
| 2001 | $15.67M | +80.3% | +$6.98M | ||
| 2000 | $8.69M | +366.8% | +$6.83M | ||
| 1999 | $1.86M | — | — |
- 2025$3.92B-0.2%
- 2024$3.93B-10.0%
- 2023$4.37B-22.8%
- 2022$5.65B+26.3%
- 2021$4.48B+54.9%
- 2020$2.89B+7.0%
- 2019$2.70B-11.5%
- 2018$3.05B+33.4%
- 2017$2.29B+16.4%
- 2016$1.97B+8.8%
- 2015$1.81B-3.7%
- 2014$1.88B+26.3%
- 2013$1.49B+19.1%
- 2012$1.25B+11.3%
- 2011$1.12B+74.7%
- 2010$641.44M+13.4%
- 2009$565.69M+7.0%
- 2008$528.50M-8.3%
- 2007$576.05M+982.0%
- 2006$53.24M+89.4%
- 2005$28.11M+24.1%
- 2004$22.64M-56.3%
- 2003$51.85M+3.4%
- 2002$50.16M+220.0%
- 2001$15.67M+80.3%
- 2000$8.69M+366.8%
- 1999$1.86M—
Total Liabilities values are taken from Illumina's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's latest reported total liabilities is $3.88B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Illumina (ILMN) total liabilities is $3.92B – edged down 0.2% year-over-year.
Through 2020–2025 (5 years), Illumina total liabilities delivered a +6.3% annualised rate; with mixed annual results across the window.
The record annual total liabilities stands at $5.65B, reached in 2022; the historical low of $1.86M was recorded in 1999.
Illumina Total Liabilities by Year
Illumina Total Liabilities 2025: $3.92B
Illumina total liabilities in 2025 was $3.92B, edged down 0.2% below 2024.
Illumina Total Liabilities 2024: $3.93B
2024's total liabilities for Illumina came in at $3.93B, declined 10.0% below 2023.
Illumina Total Liabilities 2023: $4.37B
Illumina posted total liabilities of $4.37B in 2023, declined 22.8% below 2022.
Illumina Total Liabilities 2022: $5.65B
In 2022, Illumina reported total liabilities of $5.65B, grew 26.3% from 2021. This figure represents the highest annual value in the available history.
Illumina Total Liabilities 2021: $4.48B
Illumina total liabilities in 2021 was $4.48B.
See more financial history for Illumina (ILMN).
Sector peers by Total Liabilities
Healthcare peers of Illumina (ILMN), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Illumina (ILMN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation